ISRCTN93391015已完成不适用
A randomised, double-blind, placebo-controlled, two-sequence, two-period, crossover study to evaluate the effect of SMP-028 on oral contraceptive pharmacokinetics in healthy female subjects
Dainippon Sumitomo Pharma Europe Ltd (UK)0 个研究点目标入组 22 人开始时间: 2010年1月19日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 22
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- Female
入选标准
- •1. Healthy female subjects aged 18 to 45 years
- •2. In good health as determined by:
- •2.1. Past medical history
- •2.2. Physical examination
- •2.3. Electrocardiogram
- •2.4. Clinical safety laboratory tests
- •2.5. Urinalysis
排除标准
- •1. Contraindications to the administration of a combined oral contraceptive (OC) pill
- •2. Other standard exclusion criteria
研究者
相似试验
招募中
1 期
A two-part study to investigate the effects in adults of two doses of a new drug called golexanolone in patients with primary biliary cholangitis with fatigue and cognitive dysfunctioEUCTR2022-000422-16-GRmecrine Cognition AB101
进行中（未招募）
1 期
A two-part study to investigate the effects in adults of two doses of a new drug called golexanolone in patients with primary biliary cholangitis with fatigue and cognitive dysfunctioPrimary biliary cholangitis (PBC)MedDRA version: 20.0Level: SOCClassification code 10019805Term: Hepatobiliary disordersSystem Organ Class: 10019805 - Hepatobiliary disordersEUCTR2022-000422-16-HUmecrine Cognition AB101
招募中
1 期
A two-part study to investigate the effects in adults of two doses of a new drug called golexanolone in patients with primary biliary cholangitis with fatigue and cognitive dysfunctioEUCTR2022-000422-16-ESmecrine Cognition AB101
进行中（未招募）
不适用
A randomised, double-blind, placebo-controlled, two-period, two-sequence-crossover interaction study to assess the effect of safinamide on levodopa pharmacokinetics in subjects with Parkinson?s disease - A study to assess the effect of safinamide on levodopa pharmacokineticsMedDRA version: 9.1Level: LLTClassification code 10013113Parkinson DiseaseEUCTR2008-002769-30-ITMERCK SERONO SA
进行中（未招募）
2 期
A two-part study to assess the effectiveness, safety, and blood levels of repeat doses of inhaled ETD001 in people with cystic fibrosisRespiratoryCystic FibrosisISRCTN11798668Enterprise Therapeutics Ltd35